Selection of phenytoin responders and nonresponders in male and female amygdala-kindled Sprague-Dawley rats

Epilepsia

Volumn 39, Issue 11, 1998, Pages 1138-1147

  Löscher, Wolfgang ^a   Cramer, Sybille ^a   Ebert, Ulrich ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Anticonvulsant drugs; Epilepsy; Kindling; Pharmacoresistance; Wistar rats

Indexed keywords

PHENYTOIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; DISEASE SEVERITY; DRUG EFFICACY; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0031769296     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01304.x     Document Type: Article

References (26)

1. Racine RJ, Ivy GO, Milgram NW. Kindling: clinical relevance and anatomical substrate. In: Bolwig TG, Trimble MR, eds. The clinical relevance of kindling. Chichester: John Wiley, 1989:15-34.
2. Sato M, Racine RJ, McIntyre DC. Kindling: basic mechanisms and clinical validity. Electroencephalogr Clin Neurophysiol 1990;76: 459-72.
3. Stark LG. Kindling: Amygdaloid neuronal networks and actions of convulsant and antiepileptic drugs. In: Faingold CL, Fromm GH, eds. Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. Boca Raton, FL: CRC Press, 1992: 195-212.
4. Löscher W. Animal models of epilepsy and epileptic seizures. In: Eadie MJ, Vajda F, eds. Antiepileptic drugs: handbook of experimental pharmacology. Berlin: Springer, 1998 (in press).
5. Johannessen SI, Gram L, Sillanpää M, Tomson T. Intractable epilepsy. Petersfield: Wrightson Biomedical Publishing, 1995.
6. Löscher W. Animal models of intractable epilepsy. Prog Neurobiol 1997;53:239-58.
7. Löscher W, Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J Pharmacol Exp Ther 1991;258:483-9.
8. Löscher W, Rundfeldt C, Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res 1993;15:207-19.
9. Ebert U, Rundfeldt C, Löscher W. Sex differences in the anticonvulsant efficacy of phenytoin in amygdala-kindled rats. Brain Res 1994;638:45-52.
10. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1986.
11. Racine RJ. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:281-94.
12. Freeman FG, Jarvis MF. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res Bull 1981;7:629-33.
13. Rundfeldt C, Hönack D, Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 1990;29:845-51.
14. Frey H-H, Löscher W, Reiche R, Schultz D. Anticonvulsant effect of primidone in the gerbil: time course and significance of the active metabolites. Pharmacology 1984;28:329-35.
15. Hönack D, Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 1995;36: 763-71.
16. Jones GL, Wimbish GH. Hydantoins. In: Frey H-H, Janz D, eds. Antiepileptic drugs. Berlin: Springer. 1985;351-420.
17. Hvidberg EF. Monitoring antiepileptic drug levels. In: Frey H-H, Janz D, eds. Antiepileptic drugs. Berlin: Springer. 1985:725-64.
18. Schmidt D, Einicke I, Haenel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. Arch Neurol 1986;43:263-5.
19. Gallaher EJ, Crabbe JCJ. Genetics of benzodiazepines, barbiturates, and anesthetics. In: Crabbe JCJ, Harris RA, eds. The genetic basis of alcohol and drug actions. New York: Plenum Press, 1991: 253-77.
20. Driscoll P. Genetically defined animal models of neurobehavioral dysfunctions. Boston: Birkhäuser, 1992.
21. Tishler DM, Weinberg KT, Hinton DR, Barbaro N, Annett GM, Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995;36:1-6.
22. Ebert U, Cramer S, Löscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn Schmiedebergs Arch Pharmacol 1997;356:341-7.
23. Jurna I. Electrophysiological effects of antiepileptic drugs. In: Frey H-H, Janz D, eds. Antiepileptic drugs. Berlin: Springer, 1985:611-58.
24. McNamara JO, Rigsbee LC, Butler LS, Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann Neurol 1989;26:675-8.
25. Oscorio I, Burnstine TH, Remler B, Manon-Espaillat R, Reed RC. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia 1989;30:230-4.
26. Löscher W, Reissmüller E, Ebert U. Anticonvulsant effect of fosphenytoin in amygdala-kindled rats: comparison with phenytoin. Epilepsy Res 1998;30:69-76.